Added to YB: 2026-01-28
Pitch date: 2026-01-26
ZEAL.CO [neutral]
Zealand Pharma A/S
-8.64%
current return
Author Info
Contrarian Cashflows publishes a monthly deep dive on a new value stock. Sign up for the newsletter.
Company Info
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
Market Cap
DKK 30.0B
Pitch Price
DKK 419.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
2.01
P/E
4.65
EV/Sales
1.56
Sector
Biotechnology
Category
value
Monday Delight: 26/01/2026 - Zealand Pharma A/S
ZEAL.CO (pass): Danish biotech w/ peptide therapeutics pipeline. Strong metrics: 54.4% ROE, 4.4x P/E, DKK 28.7B mkt cap vs DKK 12.9B EV. Recent Roche funding deal + potential milestones could drive EV near zero. Author passes due to complexity requiring pharma expertise.
Read full article (1 min)